OTC:CC - Ocumetics Webinar - Accommodating Intraocular Lens Update
(TheNewswire)
Calgary, Alberta – August 27,2025 – TheNewswire - Ocumetics Technology Corp . (“Ocumetics”or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leaderin advanced ophthalmic technology, is pleased to announce that it isholding a webinar to discuss the initial Ocumetics Lensimplantations.
Webinar details are as follows:
Date: Thursday, August 28,2025
Time: 6:00 PM ET
Join Ocumetics Director and CEO, Dean Burns, for anexclusive webinar covering important updates on our first-in-human(FIH) study and what lies ahead.
Topics will include:
1. Encouraging outcomes from initial surgeries
2. Next steps to complete the FIH study
3. Live Q&A session with Dean Burns
This is a timely opportunity to gain insight intoOcumetics’ progress at this critical stage of development.
Reserve your spot now at www.ocumetics.com/webinar .
About Ocumetics
Ocumetics Technology Corp. ( TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO)is a Canadian research and product development company that is dedicated to developing advanced visioncorrection solutions that enhance the quality of life for patients. Through innovative research and development, Ocumetics aims totransform the field of ophthalmology with state-of-the-art intraocularlenses and other vision-enhancing technologies.
Ocumetics is in the preclinical study phase of agame-changing technology for the ophthalmic industry. Ocumetics hasdeveloped an intraocular lens that fits within the natural lenscompartment of the eye, potentially to eliminate the need forcorrective lenses. It is designed to allow the eye’s naturalmuscle activity to shift focus from distance to near, providing clearvision at all distances without the help of glasses or contact lenses.
FOR FURTHER INFORMATION, PLEASECONTACT:
Dean Burns Roger Jewett
President and Chief Executive Officer ChiefFinancial Officer
(817) 874-7564 roger.jewett@ocumetics.com
Neither the TSXVenture Exchange nor its Regulation Services Provider (as that term isdefined in the policies of the TSX Venture Exchange) acceptsresponsibility for the adequacy or accuracy of this release.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKINGINFORMATION: This news release includes certain “forward-lookingstatements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to,statements with respect to the commencement, timing and scope of theresearch and development to be conducted by the Corporation mentionedabove. Forward-looking statements are necessarily based upon anumber of estimates and assumptions that, while considered reasonable,are subject to known and unknown risks, uncertainties, and otherfactors which may cause the actual results and future events to differmaterially from those expressed or implied by such forward-lookingstatements. Such factors include but are not limited to: operationalmatters, historical trends, current conditions and expected futuredevelopments, access to financing as well as other considerations thatare believed to be appropriate in the circumstances. There can be noassurance that such statements will prove to be accurate, as actualresults and future events could differ materially from thoseanticipated in such statements. Accordingly, readers should not placeundue reliance on forward-looking statements. The Corporationdisclaims any intention or obligation to update or revise anyforward-looking statements, whether as a result of new information,future events or otherwise, except as required by law.
Copyright (c) 2025 TheNewswire - All rights reserved.